IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy [TUMOR IMMUNOLOGY] - Ngai, H., Tian, G., Courtney, A. N., Ravari, S. B., Guo, L., Liu, B., Jin, J., Shen, E. T., Di Pierro, E. J., Metelitsa, L. S. (The American Association of Immunologists (AAI), 2018)
6333409